Aclaris Therapeutics to Participate in Two September Healthcare Conferences
Provided By GlobeNewswire
Last update: Aug 27, 2025
WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in September.
Read more at globenewswire.com
